Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cassava Sciences Inc (SAVA)

Cassava Sciences Inc (SAVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,239,351
  • Shares Outstanding, K 40,017
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,330 K
  • 60-Month Beta 0.48
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 8.68
Trade SAVA with:

Options Overview Details

View History
  • Implied Volatility 160.76%
  • Historical Volatility 215.48%
  • IV Percentile 76%
  • IV Rank 32.15%
  • IV High 283.69% on 02/02/21
  • IV Low 102.51% on 05/14/21
  • Put/Call Vol Ratio 0.83
  • Today's Volume 12,530
  • Volume Avg (30-Day) 36,883
  • Put/Call OI Ratio 0.89
  • Today's Open Interest 113,019
  • Open Int (30-Day) 165,471

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate -0.40
  • Number of Estimates 2
  • High Estimate -0.39
  • Low Estimate -0.40
  • Prior Year -0.09
  • Growth Rate Est. (year over year) -344.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.18 +32.67%
on 11/01/21
100.00 -44.04%
on 11/04/21
+8.79 (+18.63%)
since 10/26/21
3-Month
39.01 +43.45%
on 09/15/21
100.00 -44.04%
on 11/04/21
-14.89 (-21.02%)
since 08/26/21
52-Week
6.70 +735.22%
on 12/29/20
146.16 -61.71%
on 07/29/21
+48.26 (+626.75%)
since 11/25/20

Most Recent Stories

More News
Is the Options Market Predicting a Spike in Cassava Sciences (SAVA) Stock?

Investors need to pay close attention to Cassava Sciences (SAVA) stock based on the movements in the options market lately.

SAVA : 55.96 (-3.60%)
Biogen's (BIIB) Aducanumab Gets CHMP's Negative Trend Vote

Biogen's (BIIB) regulatory application seeking approval for its Alzheimer's drug, Aduhelm, in Europe hits setback as it receives negative trend vote from the CHMP.

BIIB : 242.90 (-2.89%)
LLY : 260.37 (-0.62%)
SRPT : 79.62 (-1.68%)
SAVA : 55.96 (-3.60%)
Cassava Sciences Initiates a Second Phase 3 Study of Simufilam for the Treatment of Patients with Alzheimer’s Disease

Second Phase 3 Study is Designed to Evaluate Safety and Efficacy of Simufilam Over 78 Weeks in 1,000 Patients with Alzheimer’s Disease...

SAVA : 55.96 (-3.60%)
Cassava (SAVA) Down on Report of SEC Investigation Into AD Program

Cassava (SAVA) tanks on reports of an investigation by the SEC related to data reports on its AD candidate.

BIIB : 242.90 (-2.89%)
PRTA : 49.15 (-8.36%)
QTRX : 43.07 (-2.02%)
SAVA : 55.96 (-3.60%)
Global Cancer Therapy Market Expected to Reach $268 Billion In 2026, With A CAGR Of 9.15%

Palm Beach, FL –November 16, 2021 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic has affected the healthcare systems globally and also has a significant impact on the cancer therapy...

HOTH : 0.8500 (unch)
SAVA : 55.96 (-3.60%)
CEI : 1.3700 (unch)
BIIB : 242.90 (-2.89%)
ICPT : 17.10 (-3.66%)
The Zacks Analyst Blog Highlights: Regeneron, Moderna, Cassava Sciences, Biohaven Pharma and Pfizer

The Zacks Analyst Blog Highlights: Regeneron, Moderna, Cassava Sciences, Biohaven Pharma and Pfizer

REGN : 643.35 (-0.75%)
PFE : 54.00 (+6.11%)
MRNA : 329.63 (+20.57%)
BHVN : 113.85 (-1.47%)
SAVA : 55.96 (-3.60%)
Biotech Stock Roundup: REGN, MRNA Post Q3 Earnings, SAVA Gains on AD Review Data

Earnings and other updates from bigwigs like Regeneron (REGN) and Moderna (MRNA) have been the biotech sector's few key highlights during the past week.

REGN : 643.35 (-0.75%)
PFE : 54.00 (+6.11%)
MRNA : 329.63 (+20.57%)
BHVN : 113.85 (-1.47%)
SAVA : 55.96 (-3.60%)
Cassava Sciences Reports Third Quarter 2021 Financial Results

AUSTIN, Texas, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s...

SAVA : 55.96 (-3.60%)
Review by Journal of Neuroscience Shows No Evidence of Data Manipulation in Technical Paper Foundational to Cassava Sciences’ Lead Drug Candidate

It states, “No evidence of data manipulation was found for Western blot data.”...

SAVA : 55.96 (-3.60%)
Artificial Intelligence Could Be About To Replace Your Doctor

FN Media Group Presents GlobalInvestmentDaily.com Market Commentary   London – November 2, 2021 – The US health and medical insurance industry is a $1.1-trillion maze that is impossible to navigate....

SAGE : 39.32 (-1.72%)
SAVA : 55.96 (-3.60%)
CMPS : 32.75 (+2.22%)
STIM : 4.12 (-4.41%)
ACHC : 57.81 (-5.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Cassava Sciences Inc. is focused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer's. Cassava Sciences Inc., formerly known as Pain Therapeutics Inc., is based in Austin, United States.

See More

Key Turning Points

3rd Resistance Point 66.70
2nd Resistance Point 64.21
1st Resistance Point 60.08
Last Price 55.96
1st Support Level 53.46
2nd Support Level 50.97
3rd Support Level 46.84

See More

52-Week High 146.16
Fibonacci 61.8% 92.89
Fibonacci 50% 76.43
Fibonacci 38.2% 59.97
Last Price 55.96
52-Week Low 6.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar